BOOK LAUNCH!

It’s finally here, the “Book Launch” for my new novel, “Welcome Home, Sir,” published by Anaphora Literary Press!

After the 13 year struggle for publishing “Matter Over Mind,” this time I seem to have done it with the speed of light. Relativity speaking. Sorry–not the time for bad puns…

Happy as a pig in sh*t

An interesting similarity between scientists and authors is that publication–be it papers or novels–always seems to be an anti-climax. After struggling to overcome reviewers’ comments, or editors concerns, the manuscript/novel is finally accepted and put “in press.”

But then, by the time the actual work is published, the scientist/author is never standing still and waiting to celebrate. No–time doesn’t stand still, and the projects and new novels move on. We are never satisfied with what we have. Although I never understood the materialist types who yearn for more and more money, I guess this is the equivalent–the never ending desire to create, learn and–well yes–to impress our peers.

But I will take a break–at least for a day–and try to smell the flowers (dead trees?) and celebrate symbolically.

For any of you out there interested in fiction portraying a real-life scientist suffering from post traumatic stress disorder, weaving around some intriguing issues within his own laboratory–this may be for you. Support a poor struggling artist (emphasis on struggling…).

Here are some links:

My Amazon author site: (note the Amazon “look inside” feature)

At Anaphora Literary Press:

My own website–where you can also grab a copy of “Matter Over Mind:”

And oh–in case you like it–please put up a sentence or two on Amazon as a reviewer. It’s amazing how much that seems to make a difference.

 

About Steve Caplan

I am a Professor of Biochemistry and Molecular Biology at the University of Nebraska Medical Center in Omaha, Nebraska where I mentor a group of students, postdoctoral fellows and researchers working on endocytic protein trafficking. My first lablit novel, "Matter Over Mind," is about a biomedical researcher seeking tenure and struggling to overcome the consequences of growing up with a parent suffering from bipolar disorder. Lablit novel #2, "Welcome Home, Sir," published by Anaphora Literary Press, deals with a hypochondriac principal investigator whose service in the army and post-traumatic stress disorder actually prepare him well for academic, but not personal success. Novel #3, "A Degree of Betrayal," is an academic murder mystery. "Saving One" is my most recent novel set at the National Institutes of Health. Now IN PRESS: Today's Curiosity is Tomorrow's Cure: The Case for Basic Biomedical Research (CRC PRESS, 2021). https://www.amazon.com/kindle-dbs/entity/author/B006CSULBW? All views expressed are my own, of course--after all, I hate advertising.
This entry was posted in research, science and tagged , , , , , , , , , . Bookmark the permalink.

10 Responses to BOOK LAUNCH!

  1. Congratulations, Steve!!!

    • Steve Caplan says:

      Thank you, Jenny! Being gratefully acknowledged in the book, I have a copy reserved for you. Where would you like me to send it?

      • FELPS says:

        Thanks, Amy! The age of Publish-on-Demand has really opneed up opportunities, both for self-publishing, which used to be a major (and almost always, losing) capital venture, and for the growing number of small presses, often family or individual run. I guess the jury is still out as to whether a non-exclusive contract with a small press is likely: a) to increase the prospects for a big press book deal, b) decrease the chances (even by the author stopping to search), c) have no impact.Thanks for all the great advice, and remember to let us non-e-bookers know when Petroplague is on paper!

  2. ricardipus says:

    I believe w00t! might be the right thing to say.

    Well done you. You’ve made at least one sale (well, when I clickety-click on it a bit later today).

  3. Heather says:

    Tardy but still well-meant congratulations, Steve! You definitely have the respect of this peer. I look forward to it.

Comments are closed.